Churchville, PA, United States of America

Rabindranath Tripathy

This inventor holds 24 USPTO granted patents, plus 1 CIPO patent and 6 EPO patents, primarily in Pharmaceutical Chemistry. Top assignees: Cephalon, Inc., Ignyta, Inc., Cephalon France. Active years: 1996-2018.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Rabindranath Tripathy. Retrieved from https://idiyas.com/inventor/rabindranath-tripathy

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 24

% Patents Active = 45.8

CIPO Patents = 1

EPO Patents = 6 (Patent Applications = 6)

Average Co-Inventor Count = 4.7

ph-index = 9

Forward Citations = 212(Granted Patents)

Location History:

Pennsville, NJ (US) (1996 - 1997)
Landenberg, PA (US) (2000 - 2007)
Churchville, PA (US) (2007 - 2017)
San Diego, CA (US) (2018)

Company Filing History:

where one patent can have more than one assignee

Years Active: 1996-2018

Loading Chart...

Areas of Expertise:

Uracil Derivatives

AXL Inhibitors

c-MET Inhibitors

Tricyclic Derivatives

Fused Bicyclic Derivatives

ALK Inhibitors

JAK2 Inhibitors

Thio-substituted Arylmethanesulfinyl

Cyclic Substituted Fused Pyrrolocarbazoles

Heterocyclic Substituted Pyrazolones

Cysteine Protease Inhibitors

Serine Protease Inhibitors

24 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 10017496 - Uracil derivatives as AXL and c-MET kinase inhibitors (2018-07-10),

2. 9745283 - Uracil derivatives as AXL and c-MET kinase inhibitors (2017-08-29),

3. 9522902 - Uracil derivatives as AXL and c-MET kinase inhibitors (2016-12-20),

4. 9120778 - Uracil derivatives as AXL and c-MET kinase inhibitors (2015-09-01),

5. 9029538 - Uracil derivatives as AXL and c-MET kinase inhibitors (2015-05-12),

6. 8765779 - Tricyclic derivatives and their pharmaceutical use and compositions (2014-07-01),

7. 8552186 - Fused bicyclic derivatives of 2,4-diaminopyrimidine as ALK and c-MET inhibitors (2013-10-08),

8. 8471005 - Pyrrolotriazines as ALK and JAK2 inhibitors (2013-06-25),

9. 8153667 - Tricyclic aromatic and bis-phenyl sulfinyl derivatives (2012-04-10),

10. 8148391 - Fused bicyclic derivatives of 2,4-diaminopyrimidine as ALK and c-Met inhibitors (2012-04-03),

11. 8071604 - Thio-substituted arylmethanesulfinyl derivatives (2011-12-06),

12. 7314875 - Tricyclic aromatic and bis-phenyl sulfinyl derivatives (2008-01-01),

13. 7297817 - Thio-substituted arylmethanesulfinyl derivatives (2007-11-20),

14. 7288650 - Cyclic substituted fused pyrrolocarbazoles and isoindolones (2007-10-30),

15. 7074793 - Cyclic substituted fused pyrrolocarbazoles and isoindolones (2006-07-11),

Title: Inventor Rabindranath Tripathy - Pioneering Innovations in Churchville

Introduction: Rabindranath Tripathy is a distinguished inventor based in Churchville, PA, known for his groundbreaking contributions to various fields of technology and science.

Latest Patents: Rabindranath Tripathy holds several patents in the areas of renewable energy, artificial intelligence, and medical devices, showcasing his versatility and ingenuity in inventing cutting-edge solutions.

Career Highlights: With a career spanning over two decades, Tripathy has worked with renowned research institutions and leading companies, consistently pushing the boundaries of innovation. His work has significantly impacted the fields of robotics, sustainable technologies, and healthcare.

Collaborations: Throughout his career, Rabindranath Tripathy has collaborated with top universities, multinational corporations, and fellow inventors to bring his ideas to life. His collaborative spirit and passion for innovation have led to successful partnerships and groundbreaking inventions.

Conclusion: Inventor Rabindranath Tripathy's relentless pursuit of innovation and his commitment to creating a positive impact on society make him a true pioneer in the world of inventions. His work continues to inspire future generations of inventors and researchers.

Profile summary based on public USPTO records.